ENZN — Viskase Holdings, Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 727510 ·
Last close
$5.75
Market Cap
$38.02M
52W High
$8.55
52W Low
$0.02
ADV30
1,491
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$356,704,992
EBITDA
$-6,137,000
Free Cash Flow
$-8,197,000
Enterprise Value
$204,226,816
Total Cash
$28,619,000
Total Debt
$151,955,008
Shares Out
6,612,125
Trailing EPS
$-9.98
Book Value
$-3.40
ROE
-32.3%
ROA
-3.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 364,356,000 | -17,268,000 | -65,494,000 | 402,142,000 | 257,782,000 | — | 12,998,000 |
| Dec 2024 | 403,775,000 | 17,800,000 | -5,360,000 | — | — | — | 3,369,000 |
| Dec 2023 | 445,984,000 | 39,721,000 | 13,506,000 | — | — | — | 44,165,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INMB | Inmune Bio, Inc. | $38.02M | $1.43 | — |
| TVGN | Tevogen Bio Holdings Inc. | $36.01M | $8.60 | — |
| EVAX | Evaxion A/S | $34.28M | $4.11 | — |
| GRML | Greenland Mines Ltd | $43.65M | $0.36 | — |
| SCLX | Scilex Holding Co | $45.05M | $6.41 | — |
News headlines (Yahoo Finance, 1h cache)
Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
2026-03-25 12:45 · Yahoo
Enzon Announces Reverse Stock Split
2026-03-24 12:45 · Yahoo
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
2026-03-19 20:30 · Yahoo
Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger
2026-01-30 22:15 · Yahoo
Enzon and Viskase Announce Amendment to Merger Agreement
2025-10-24 20:50 · Yahoo
Enzon and Viskase Enter into Merger Agreement
2025-06-21 00:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.